Biocon Biologics
Anupama D S has extensive experience in the biotech industry, with roles at Biocon Biologics, Biocon, and Biocon Research Limited. Currently serving as the Head of Quality PMO at Biocon Biologics, Anupama has held various titles such as Senior Manager, Global Program Management, Senior Manager, Global Regulatory Lead, and Program Manager in the past. With a background in biotechnology and biochemistry from Bangalore University, Anupama has demonstrated expertise in analytical method development for proteins and HPLC method development for biosimilars.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics